Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 97
Filter
Add more filters

Complementary Medicines
Publication year range
1.
Phytother Res ; 38(3): 1262-1277, 2024 Mar.
Article in English | MEDLINE | ID: mdl-38185917

ABSTRACT

Hippocampal synaptic dysfunction, oxidative stress, neuroinflammation, and neuronal loss play critical roles in the pathophysiology of diabetes-associated cognitive decline (DACD). The study aimed to investigate the effects of vanillic acid (VA), a phenolic compound, against DACD and explore the potential underlying mechanisms. Following confirmation of diabetes, rats were treated with VA (50 mg/kg/day; P.O.) or insulin (6 IU/rat/day; S.C.) for 8 consecutive weeks. The cognitive performance of the rats was evaluated using passive-avoidance and water-maze tasks. Long-term potentiation (LTP) was induced at hippocampal dentate gyrus (DG) synapses in response to high-frequency stimulation (HFS) applied to the perforant pathway (PP) to evaluate synaptic plasticity. Oxidative stress factors, inflammatory markers, and histological changes were evaluated in the rat hippocampus. This study showed that streptozotocin (STZ)-induced diabetes caused cognitive decline that was associated with inhibition of LTP induction, suppression of enzymatic antioxidant activities, enhanced lipid peroxidation, elevated levels of inflammatory proteins, and neuronal loss. Interestingly, chronic treatment with VA alleviated blood glucose levels, improved cognitive decline, ameliorated LTP impairment, modulated oxidative-antioxidative status, inhibited inflammatory response, and prevented neuronal loss in diabetic rats at a level comparable to insulin therapy. The results suggest that the antihyperglycemic, antioxidative, anti-inflammatory, and neuroplastic properties of VA may be the mechanisms behind its neuroprotective effect against DACD.


Subject(s)
Cognitive Dysfunction , Diabetes Mellitus, Experimental , Neuroprotective Agents , Rats , Animals , Diabetes Mellitus, Experimental/complications , Neuroprotective Agents/pharmacology , Vanillic Acid/pharmacology , Rats, Wistar , Hippocampus , Antioxidants/pharmacology , Neuronal Plasticity , Cognitive Dysfunction/pathology , Insulin
2.
Life Sci ; 334: 122190, 2023 Dec 01.
Article in English | MEDLINE | ID: mdl-37866805

ABSTRACT

BACKGROUND: The search for alternative therapies for treatment of Benign prostatic hyperplasia (BPH) has been increasingly studied to avoid the common adverse effects of the usual regimens. Therefore, this study aimed at delineating possible mechanisms of benign prostatic hyperplasia (BPH) and possible therapeutic role of zinc oxide nanoparticles (ZnO-NPs) versus vanillic acid. METHODS: Forty rats were divided into five groups: control, sham control, Testosterone-induced BPH, BPH and Zn-NPs, and BPH and vanillic acid. Light microscopic, immune-histochemical; PCNA, Bcl-2, Bax, caspase-3, p-Akt and p-mTOR, histomorphometric analysis, MDA/SOD and GPx and were done. Gene expression of p-Akt, p-mTOR and survivin were evaluated. RESULTS: Application of zinc oxide nanoparticles as well as vanillic acid significantly reduced prostatic index, epithelial thickness, stromal collagen fibers, expression of PCNA, Bcl2, p-Akt, p-mTOR and MDA tissue level (p < 0.05). Whereas expression of Bax and caspase 3, and tissue levels of SOD and GPx were significantly increased in groups treated with Zno-Nps and vanillic acid compared to that of BPH group. Zinc oxide nanoparticles showed a better effect than vanillic acid in alleviating BPH. CONCLUSION: These findings suggested that ZnO-NPs as well as VA ameliorated the histolo-pathological and biochemical effects of induced BPH, moreover they improved the proapoptotic and antioxidant parameters which ere induced in BPH. It is recommended to search for new agents to prevent the development and progression of BPH.


Subject(s)
Nanoparticles , Prostatic Hyperplasia , Zinc Oxide , Male , Humans , Rats , Animals , Testosterone/metabolism , Prostatic Hyperplasia/chemically induced , Prostatic Hyperplasia/drug therapy , Prostatic Hyperplasia/metabolism , Zinc Oxide/therapeutic use , Vanillic Acid/pharmacology , Vanillic Acid/therapeutic use , Proto-Oncogene Proteins c-akt , bcl-2-Associated X Protein , Proliferating Cell Nuclear Antigen , TOR Serine-Threonine Kinases , Superoxide Dismutase
3.
Nutrients ; 15(10)2023 May 10.
Article in English | MEDLINE | ID: mdl-37242140

ABSTRACT

Vanillic acid (VA) has shown antioxidant and anti-inflammatory activities in different cell types, but its biological effects in the context of early embryo development have not yet been clarified. In the current study, the impact of VA supplementation during in vitro maturation (IVM) and/or post-fertilization (in vitro culture; IVC) on redox homeostasis, mitochondrial function, AKT signaling, developmental competence, and the quality of bovine pre-implantation embryos was investigated. The results showed that dual exposure to VA during IVM and late embryo culture (IVC3) significantly improved the blastocyst development rate, reduced oxidative stress, and promoted fatty acid oxidation as well as mitochondrial activity. Additionally, the total numbers of cells and trophectoderm cells per blastocyst were higher in the VA-treated group compared to control (p < 0.05). The RT-qPCR results showed down-regulation of the mRNA of the apoptosis-specific markers and up-regulation of AKT2 and the redox homeostasis-related gene TXN in the treated group. Additionally, the immunofluorescence analysis showed high levels of pAKT-Ser473 and the fatty acid metabolism marker CPT1A in embryos developed following VA treatment. In conclusion, the study reports, for the first time, the embryotrophic effects of VA, and the potential linkage to AKT signaling pathway that could be used as an efficacious protocol in assisted reproductive technologies (ART) to improve human fertility.


Subject(s)
In Vitro Oocyte Maturation Techniques , Oocytes , Animals , Cattle , Humans , Oocytes/metabolism , In Vitro Oocyte Maturation Techniques/methods , Proto-Oncogene Proteins c-akt/metabolism , Vanillic Acid/pharmacology , Oxidative Stress , Embryonic Development , Signal Transduction , Fatty Acids/metabolism
4.
Molecules ; 27(23)2022 Nov 28.
Article in English | MEDLINE | ID: mdl-36500401

ABSTRACT

In the current study, the hepatoprotective activity of vanillic acid, silymarin, and vanillic acid-loaded silver nanoparticles (AgNPs) against CCl4-induced hepatotoxicity was tested in male rats for four weeks. Thirty male rats were divided into five groups (n = 6). The 1st group was a negative control, the 2nd group was a positive control, the 3rd group was treated with 100 mg/kg b.w. of vanillic acid, the 4th group was treated with 100 mg/kg b.w. of vanillic acid-AgNPs, and the 5th group was treated with 50 mg/kg b.w. of silymarin. The CCl4-induced hepatic toxicity in the 2nd group was revealed by the liver function and all other biochemical tests. Liver enzymes, bilirubin, lipid peroxidation, lactate dehydrogenase, and interleukin-6 were elevated, whereas, total protein, antioxidant enzymes, and irisin were decreased compared to the negative control. The hepatic tissues were also injured as a result of the CCl4-induced hepatotoxicity. Treating the hepatotoxic rats with vanillic acid moderately protected the rats of the 3rd group, whereas treatment with vanillic AgNPs and silymarin in G4 and G5, respectively, greatly protected the rats against the CCl4 hepatotoxicity, approaching the normal biochemical levels and liver tissue appearance. The biochemical tests were confirmed by the histological investigations of liver tissue.


Subject(s)
Chemical and Drug Induced Liver Injury , Metal Nanoparticles , Silymarin , Rats , Male , Animals , Carbon Tetrachloride/toxicity , Chemical and Drug Induced Liver Injury/metabolism , Vanillic Acid/pharmacology , Vanillic Acid/metabolism , Silver/metabolism , Plant Extracts/pharmacology , Carbon/metabolism , Silymarin/pharmacology , Antioxidants/pharmacology , Antioxidants/metabolism , Liver/metabolism
5.
Molecules ; 27(20)2022 Oct 14.
Article in English | MEDLINE | ID: mdl-36296486

ABSTRACT

Alzheimer's disease is the most common neurodegenerative disease, characterized by memory loss and cognitive dysfunction. Raspberry fruits contain polyphenols which have antioxidant and anti-inflammatory properties. In this study, we used molecular imprinting technology to efficiently isolate phenolic components from the raspberry ethyl acetate extracts. Six phenolic components (ellagic acid, tiliroside, kaempferol-3-o-rutoside, gallic acid, ferulic acid and vanillic acid) were identified by UPLC-Q-TOF-MS analysis. Molecular docking was used to predict the anti-inflammatory effects and anti-Alzheimer's potential of these isolated compounds, which showed a good binding ability to diseases and related proteins. However, the binding energy and docking fraction of ellagic acid, tiliroside, and kaempferol-3-o-rutoside were better than those of gallic acid, ferulic acid and vanillic acid. Additionally, by studying the effects of these six phenolic components on the LPS-induced secretion of inflammatory mediators in murine microglial (BV2) cells, it was further demonstrated that they were all capable of inhibiting the secretion of NO, IL-6, TNF-α, and IL-1ß to a certain extent. However, ellagic acid, tiliroside, and kaempferol-3-o-rutoside have better inhibitory effects compared to others. The results obtained suggest that the phenolic components extracted from ethyl acetate extracts of raspberry by molecularly imprinted polymers have the potential to inhibit the progression of Alzheimer's disease.


Subject(s)
Molecular Imprinting , Neurodegenerative Diseases , Rubus , Mice , Animals , Rubus/chemistry , Antioxidants/chemistry , Kaempferols/pharmacology , Ellagic Acid/pharmacology , Ellagic Acid/analysis , Molecular Docking Simulation , Tumor Necrosis Factor-alpha , Vanillic Acid/pharmacology , Molecularly Imprinted Polymers , Interleukin-6 , Lipopolysaccharides , Plant Extracts/chemistry , Anti-Inflammatory Agents/pharmacology , Gallic Acid/pharmacology , Rutin , Inflammation Mediators
6.
Reprod Fertil ; 3(3): 220-230, 2022 07 01.
Article in English | MEDLINE | ID: mdl-35980228

ABSTRACT

Abstract: Di-2-ethylhexyl phthalate (DEHP) is an extensively used plasticizer which has raised some concerns about its safety on human health. This study aimed at evaluating the effects of vanillic acid (VA) and vitamin C (VC) supplementation on DEHP-induced testicular toxicity. Thirty-five adult male Wistar rats were randomly divided into 7 groups (A-G) (n = 5) receiving distilled water; 250 mg/kg bw of DEHP only; 30 mg/kg bw of VA and 250 mg/kg bw of DEHP; 30 mg/kg bw of VC and 250 mg/kg bw of DEHP; 30 mg/kg bw of DEHP plus 30 mg/kg bw of VA and 30 mg/kg bw of VC; 30 mg/kg bw of VA only; and 30 mg/kg bw of VC only, respectively. At the end of the experiment, blood was taken from the heart via cardiac puncture and stored, semen was collected from the caudal epididymis for immediate sperm analysis, while the testes were excised and preserved for histological examination and biochemical analysis. The results showed a significant decrease (P < 0.05) in body weights, sperm motility, sperm volume, sperm viability and count, antioxidant levels, and reproductive hormonal levels, with a significant increase (P < 0.05) in sperm morphological defect and lipid peroxidation level in DEHP-only group compared with the control but was ameliorated after VA and VC administration compared to the DEHP-only treated animals. VA and VC supplementation attenuated the toxic effects of DEHP on the testicular functions, morphology, and semen characterization of the experimental adult male Wistar rats. Lay summary: Male infertility is considered when identifiable female causes of infertility are excluded and semen quantity and quality fail to fulfil World Health Organization criteria. From conception through to adulthood, people are exposed to limitless environmental toxicants among which di-2-ethylhexyl phthalate (DEHP) commonly found in personal care products, cosmetics, and medical devices is prevalent. The present study elaborated on the importance of taking antioxidant-rich foods containing vitamin C and vanillic acid, such as those found in various fruits, olives, whole wheat, and cereal grains, in combating infertility caused by environmental toxicants. An experiment was carried out on rats to see the effect of vanillic acid and vitamin C supplementation on preventing DEHP-induced testicular toxicity. The testicles and semen were analyzed from five rats in each treated and control groups. The data led us to conclude that vanillic acid and vitamin C supplementation do have attenuating effects on DEHP-induced testicular toxicity, due to their high antioxidant and anti-inflammatory properties.


Subject(s)
Diethylhexyl Phthalate , Infertility, Male , Rodent Diseases , Rats , Male , Female , Humans , Animals , Testis/pathology , Antioxidants/pharmacology , Vanillic Acid/pharmacology , Diethylhexyl Phthalate/toxicity , Rats, Wistar , Ascorbic Acid/pharmacology , Sperm Motility , Semen , Vitamins/pharmacology , Infertility, Male/chemically induced , Infertility, Male/prevention & control , Infertility, Male/pathology , Infertility, Male/veterinary , Rodent Diseases/pathology
7.
J Sci Food Agric ; 102(14): 6718-6726, 2022 Nov.
Article in English | MEDLINE | ID: mdl-35620810

ABSTRACT

BACKGROUND: This study investigated the inhibitory efficiency of phenolic compounds content methyl vanillate, syringic acid and vanillic acid against α-glucosidase and α-amylase. The phenolic compound contents of 10 Thai colored rice cultivars were also determined, and the relationship between the inhibitory efficiency of colored rice extract with methyl vanillate, syringic acid and vanillic acid was evaluated. RESULTS: The results revealed that the inhibition efficiency of methyl vanillate, syringic acid and vanillic acid was higher against α-glucosidase than against α-amylase. Inhibitory activity of vanillic acid against α-glucosidase and α-amylase was highest, with IC50 of 0.100 ± 0.01 and 0.130 ± 0.02 mmol L-1 , respectively. Docking study showed strong binding by three hydrogen bonds and four hydrogen bonds between vanillic acid with the amino acid in the binding site of α-glucosidase and α-amylase, respectively. Inhibition modes of these phenolic compounds were defined as a mixed type inhibition against α-glucosidase. Highest phenolic compound contents of methyl vanillate, syringic acid and vanillic acid were obtained from methanol extracts of all rice cultivars. The methanol extracts of all colored rice cultivars such as Khao Leum Pua also showed the highest inhibition potential against α-glucosidase and α-amylase. The results indicated that these phenolic compound contents were closely related to the inhibition potential of colored rice extracts against α-glucosidase and α-amylase. CONCLUSION: Our results suggest that rice, especially colored rice cultivars, has the source of phenolic compounds. Moreover, the phenolic compounds had the greatest source of natural inhibitor against α-glucosidase and α-amylase. © 2022 Society of Chemical Industry.


Subject(s)
Oryza , alpha-Glucosidases , Amino Acids , Antioxidants/pharmacology , Gallic Acid/analogs & derivatives , Glycoside Hydrolase Inhibitors/pharmacology , Methanol , Oryza/metabolism , Phenols/chemistry , Plant Extracts/chemistry , Plant Extracts/pharmacology , Thailand , Vanillic Acid/analogs & derivatives , Vanillic Acid/pharmacology , alpha-Amylases , alpha-Glucosidases/metabolism
8.
Phytother Res ; 36(3): 1338-1352, 2022 Mar.
Article in English | MEDLINE | ID: mdl-35088468

ABSTRACT

Diabetes is the most prevalent disorder in the world characterized by uncontrolled high blood glucose levels and nephropathy is one of the chief complications allied with hyperglycemia. Vanillic acid; the main bioactive compound derived from natural sources such as vegetables, fruits and plants possesses various pharmacological activities such as antioxidant, anti-inflammatory and anti-proliferative. The current study was designed to investigate the antidiabetic and renoprotective effects of vanillic acid by its various pharmacological activities. Streptozotocin (50 mg/kg)/nicotinamide (110 mg/kg) was used to induce diabetes in rats. Oral administration of vanillic acid once daily for 6 weeks (25, 50 and 100 mg/kg) significantly reduced the hyperglycemia, increased liver enzymes and normalized lipid profile that was altered in diabetic rats. Moreover, vanillic acid attenuated the impaired renal function as evidenced by a reduction in serum creatinine, urea, uric acid and urinary microproteinuria levels with a concomitant increase in urinary creatinine clearance in the nephropathic rats. Diabetic rats showed a marked increase in thiobarbituric acid reactive substances (TBARS) and superoxide anion generation (SAG) along with decreased reduced glutathione (GSH) in the renal tissue which was ameliorated in the vanillic acid-treated rats. Histopathologically, vanillic acid treatment was associated with reduced damage with normalized structural changes in renal tissue. Furthermore, treatment groups showed the suppression of upregulation of nuclear factor (NF)-κB, tumor necrosis factor (TNF)-α, cyclo-oxygenase (COX)-2 and up-regulation of Nuclear factor-erythroid 2-related factor 2 (Nrf-2) in the renal tissue. In conclusion, vanillic acid's ameliorative impact on diabetic nephropathic rats may be attributed to its powerful free radical scavenging property, down-regulation of NF-κB, TNF-α, COX-2 and up-regulation of Nrf-2 proteins in renal tissue.


Subject(s)
Diabetes Mellitus, Experimental , Diabetic Nephropathies , Animals , Cyclooxygenase 2/metabolism , Diabetes Mellitus, Experimental/metabolism , Diabetic Nephropathies/drug therapy , Diabetic Nephropathies/pathology , Kidney , NF-kappa B/metabolism , Oxidative Stress , Rats , Tumor Necrosis Factor-alpha/metabolism , Up-Regulation , Vanillic Acid/metabolism , Vanillic Acid/pharmacology , Vanillic Acid/therapeutic use
9.
Drug Chem Toxicol ; 45(6): 2814-2824, 2022 Nov.
Article in English | MEDLINE | ID: mdl-34663156

ABSTRACT

Morus nigra L. is a plant popularly known as 'amoreira preta', very used in folk medicine. Iron overload (hemochromatosis) is a clinical condition that causes damage to various tissues due to oxidative stress. Therapy to control iron overload is still unsatisfactory. The protective effect on oxidative stress induced by iron overload was verified. Phytochemical characterization was evaluated by UHPLC-MS/MS. The in silico toxicity predictions of the main phytochemicals were performed via computer simulation. To induce iron overload, the animals received iron dextran (50 mg/kg/day). The test groups received doses of 500 and 1000 mg/kg of M. nigra extract for six weeks. Body weight, organosomatic index, serum iron, hepatic markers, cytokines, interfering factors in iron metabolism, enzymatic and histopathological evaluations were analyzed. Vanillic acid, caffeic acid, 6-hydroxycoumarin, p-coumaric acid, ferulic acid, rutin, quercitrin, resveratrol, apigenin and kaempferol were identified in the extract. In addition, in silico toxic predictions showed that the main compounds presented a low probability of toxic risk. The extract of M. nigra showed to control the mediators of inflammation and to reduce iron overload in several tissues. Our findings illustrate a novel therapeutic action of M. nigra leaves on hemochromatosis caused by iron overload.


Subject(s)
Hemochromatosis , Iron Overload , Morus , Animals , Morus/chemistry , Morus/metabolism , Kaempferols/analysis , Kaempferols/pharmacology , Resveratrol/pharmacology , Hemochromatosis/drug therapy , Apigenin/analysis , Apigenin/pharmacology , Vanillic Acid/pharmacology , Tandem Mass Spectrometry , Computer Simulation , Dextrans/analysis , Dextrans/metabolism , Dextrans/pharmacology , Plant Extracts/therapeutic use , Plant Leaves/chemistry , Oxidative Stress , Iron Overload/prevention & control , Phytochemicals/analysis , Rutin/pharmacology , Iron/toxicity , Iron/analysis , Cytokines/metabolism , Inflammation Mediators/metabolism
10.
J Pharm Pharmacol ; 73(12): 1703-1714, 2021 Dec 07.
Article in English | MEDLINE | ID: mdl-34109975

ABSTRACT

OBJECTIVES: Our aim was to synthesize, characterize and evaluate the antihyperglycaemic and anti-oxidative properties of a new Zn(II) complex of vanillic acid. METHODS: The complex was synthesized using ZnSO4.7H2O and vanillic acid as precursors. NMR and FTIR techniques were used to characterize the synthesized complex. The cytotoxicity of the complex was measured. The antihyperglycemic and anti-oxidative properties of the complex were evaluated using in vitro, cell-based and ex vivo models and compared with those of its precursors. KEY FINDINGS: Zn(II) coordinated with vanillic acid via a Zn(O6) coordination, with the complex having three moieties of vanillic acid. The radical scavenging, Fe3+ reducing and hepatic antilipid peroxidative activity of the complex were, respectively, 2.3-, 1.8- and 9.7-folds more potent than vanillic acid. Complexation increased the α-glucosidase and glycation inhibitory activity of vanillic acid by 3- and 2.6-folds, respectively. Zn(II) conferred potent L-6 myotube (EC50 = 20.4 µm) and muscle tissue (EC50 = 612 µm) glucose uptake effects on vanillic acid. Cytotoxicity evaluation showed that the complex did not reduce the viability of L-6 myotubes and Chang liver cells. CONCLUSIONS: The data suggest that Zn(II)-vanillic acid complex had improved bioactivity relative to vanillic acid. Thus, Zn(II) may be further studied as an antihyperglycaemic and anti-oxidative adjuvant for bioactive phenolic acids.


Subject(s)
Antioxidants/pharmacology , Glucose/metabolism , Hypoglycemic Agents/pharmacology , Oxidative Stress/drug effects , Plant Extracts/pharmacology , Vanillic Acid/pharmacology , Zinc/pharmacology , Animals , Coordination Complexes , Diabetes Mellitus/metabolism , Organometallic Compounds , Rats, Sprague-Dawley
11.
Behav Brain Res ; 412: 113403, 2021 08 27.
Article in English | MEDLINE | ID: mdl-34090940

ABSTRACT

The developmental period is critical in delineating plastic response to internal and external events. However, neurobehavioural effects of global cerebral ischemia (GCI) in the maturing brain remain largely unknown. This study characterised the effects of GCI experienced at puberty on adulthood (1) hippocampus CA1 neuronal damage, (2) cognitive and emotional impairments, and (3) glucocorticoid receptor (GR) expression. Effects of adolescent exposure to the phenol vanillic acid (VA) on post-ischemic outcomes were also determined. Male Long Evans rats (n = 35) were supplemented for 21 consecutive days (postnatal days 33-53) with VA (91 mg/kg) or nut paste vehicle (control) prior to a 10-min GCI or sham surgery. As adults, rats were tested in the Open Field Test (OFT), Elevated-Plus Maze (EPM), and Barnes Maze (BM). GR expression was determined in the basolateral amygdala (BLA), CA1, and paraventricular nucleus (PVN), and brain injury assessed via CA1 neuronal density. Adolescent GCI exposure induced extensive hippocampal CA1 injury, which was not prevented by VA supplementation. Behaviourally, GCI increased EPM exploration while having no impact on spatial memory. VA intake increased OFT peripheral exploration. Notably, while no delayed changes in CA1 and PVN GR immunoreactivity were noted, both treatments separately increased BLA GR expression when compared with sham-nut paste rats. Age at GCI occurrence plays a critical role on post-ischemic impairments. The observation of minimal functional impairments despite important CA1 neuronal damage supports use of compensatory mechanisms. Our findings also show daily VA supplementation during adolescence to have no protective effects on post-ischemic outcomes, contrasting adult intake.


Subject(s)
Brain Ischemia/drug therapy , Vanillic Acid/pharmacology , Age Factors , Animals , Brain Ischemia/physiopathology , CA1 Region, Hippocampal/physiopathology , Dietary Supplements , Hippocampus/metabolism , Impulsive Behavior/physiology , Male , Neurons/metabolism , Neuroprotective Agents/pharmacology , Rats , Rats, Long-Evans , Sexual Maturation/drug effects , Sexual Maturation/physiology , Vanillic Acid/metabolism
12.
Zhongguo Zhong Yao Za Zhi ; 45(2): 367-373, 2020 Jan.
Article in Chinese | MEDLINE | ID: mdl-32237320

ABSTRACT

To identify and verify the active ingredients from Astragalus membranaceus on hypertensive cardiac remodeling based on network pharmacology and heart RNA-sequencing data. The monomers of A. membranaceus and their intervention target database were established by using network pharmacology. The genes associated to cardiac remodeling were then screened by analyzing cardiac RNA-sequencing data. An overlap between genes related to cardiac remodeling and targets of ingredients form A. membranaceus was collected to obtain monomers with protective effect on hypertensive cardiac remodeling. Angiotensin Ⅱ(AngⅡ)-induced mouse cardiac remodeling model was used to validate the protective effect of active ingredients from A. membranaceus on hypertensive cardiac remodeling. Finally, a total of 81 monomers and 1 197 targets were enrolled in our database. Mouse RNA-sequencing data showed that 983 genes were significantly up-regulated and 465 genes were down-regulation in myocardial tissues of the cardiac remodeling mice as compared with blank group mice, respectively. Ninety-two genes were found via overlapping between genes related to cardiac remodeling and targets, involving 59 monomers from A. membranaceus. Further research found that vanillic acid(VA) could intervene 27 genes associated with hypertensive cardiac remodeling, ranking top 1. Meanwhile, VA could significantly inhibit AngⅡ-induced increase in ratio of heart weight to body weight and heart weight to tibial length, ANP and BNP mRNA levels in myocardial tissues, myocardial tissue damage, cardiac fibrosis level and cardiac hypertrophy level in vivo. Those results showed that network pharmacology screen-based VA has protective effect on AngⅡ-induced cardiac remodeling.


Subject(s)
Astragalus propinquus/chemistry , Hypertension/genetics , Vanillic Acid/pharmacology , Ventricular Remodeling/drug effects , Angiotensin II , Animals , Heart , Mice , Protective Agents/pharmacology , Ventricular Remodeling/genetics
13.
Pak J Pharm Sci ; 33(5(Supplementary)): 2219-2230, 2020 Sep.
Article in English | MEDLINE | ID: mdl-33832894

ABSTRACT

Sorghum halepense L (Poaceae), ordinarily it is known as Johnson grass and locally as baru. This study was designed to find the vascular mechanisms underlying the hypotensive activity of S. halepense. In this study, effect of S. halepense seed extract/fractions on various blood pressure parameters were evaluated in normal and fructose induced hypertensive rats by invasive technique. Possible underlying hypotensive mechanism of active fraction was determined by using various pharmacological inhibitors. S. halepense extract/fractions vasorelaxant effect were also evaluated on rat aorta rings in organ bath and various intracellular signaling pathway inhibitors were used for determination of underlying mechanisms. S. halepense extract/fractions produced blood pressure lowering effect with most significant effect by its aqueous soluble fraction at dose of 10mg/kg. This effect was attenuated by pretreatment of atropine. Aqueous soluble fraction produced endothelium dependent vasorelaxation in rat aortic rings that was inhibited by pretreatment of atropine after phenylephrine induced contraction. The vasorelaxant effect of aqueous soluble fraction was attenuated by potassium channel blockers and also produced inhibitory effect on calcium entry through calcium channels. It also suppressed phenylephrine induced contraction like verapamil. By HPLC analysis found vanillic acid and naringinin in it. In conclusion, aqueous soluble fraction of S.halepense possess phytoconstituents which may be responsible for hypotensive and vasorelaxant effect of Sorghum halepense.


Subject(s)
Antihypertensive Agents/pharmacology , Blood Pressure/drug effects , Hypertension/drug therapy , Plant Extracts/pharmacology , Sorghum , Vasodilation/drug effects , Vasodilator Agents/pharmacology , Animals , Antihypertensive Agents/isolation & purification , Disease Models, Animal , Flavanones/isolation & purification , Flavanones/pharmacology , Fructose , Hypertension/chemically induced , Hypertension/metabolism , Hypertension/physiopathology , Male , Plant Extracts/isolation & purification , Rats, Sprague-Dawley , Sorghum/chemistry , Vanillic Acid/isolation & purification , Vanillic Acid/pharmacology , Vasodilator Agents/isolation & purification
14.
Biomolecules ; 9(11)2019 11 12.
Article in English | MEDLINE | ID: mdl-31726713

ABSTRACT

Low-density lipoprotein (LDL) and high-density lipoprotein (HDL) oxidation are well known to increase the risk for atherosclerosis. In our ongoing research on natural products with inhibitory activities against oxidation of lipoproteins, fruits of Vitex rotundifolia were found to be highly active. There is no report on the effects on LDL and HDL oxidation. Herein, we investigated the inhibitory effects of V. rotundifolia fruit extract and its six compounds, which are: (1) artemetin, (2) casticin, (3) hesperidin, (4) luteolin, (5) vitexin, and (6) vanillic acid, against LDL and HDL oxidation. The LDL and HDL oxidations were determined by measuring production of conjugated dienes and thiobarbituric acid reactive substances, amount of hyperchromicity and carbonyl content, change in electrical charge, and apoA-I aggregation. In addition, the contents of the compounds in the extracts were analyzed using HPLC-DAD. Consequently, extracts of Vitex rotundifolia fruits and compounds 2 and 4 suppressed oxidation of LDL and HDL, showing inhibition of lipid peroxidation, decrease of negative charges in lipoproteins, reduction of hyperchromicity, decrease in carbonyl contents, and prevention of apoA-I aggregation. In particular, compounds 2 and 4 exhibited more potent inhibitory effect on oxidation of LDL and HDL than the extracts, suggesting their protective role against atherosclerosis via inhibition of LDL and HDL oxidation. The contents of artemetin, casticin, and vanillic acid in the extracts were 1.838 ± 0.007, 8.629 ± 0.078, and 1.717 ± 0.006 mg/g, respectively.


Subject(s)
Atherosclerosis/drug therapy , Lipid Peroxidation/drug effects , Plant Extracts/pharmacology , Vitex/chemistry , Apigenin/pharmacology , Apolipoprotein A-I/antagonists & inhibitors , Apolipoprotein A-I/chemistry , Apolipoprotein A-I/genetics , Atherosclerosis/genetics , Atherosclerosis/metabolism , Chromatography, High Pressure Liquid , Flavonoids/pharmacology , Fruit/chemistry , Hesperidin/pharmacology , Humans , Lipoproteins, HDL/antagonists & inhibitors , Lipoproteins, HDL/metabolism , Lipoproteins, LDL/antagonists & inhibitors , Lipoproteins, LDL/metabolism , Luteolin/pharmacology , Plant Extracts/chemistry , Protein Aggregates/drug effects , Vanillic Acid/pharmacology
15.
Oxid Med Cell Longev ; 2019: 3904905, 2019.
Article in English | MEDLINE | ID: mdl-31379988

ABSTRACT

Coenzyme Q (CoQ), a redox-active lipid, is comprised of a quinone group and a polyisoprenoid tail. It is an electron carrier in the mitochondrial respiratory chain, a cofactor of other mitochondrial dehydrogenases, and an essential antioxidant. CoQ requires a large set of enzymes for its biosynthesis; mutations in genes encoding these proteins cause primary CoQ deficiency, a clinically and genetically heterogeneous group of diseases. Patients with CoQ deficiency often respond to oral CoQ10 supplementation. Treatment is however problematic because of the low bioavailability of CoQ10 and the poor tissue delivery. In recent years, bypass therapy using analogues of the precursor of the aromatic ring of CoQ has been proposed as a promising alternative. We have previously shown using a yeast model that vanillic acid (VA) can bypass mutations of COQ6, a monooxygenase required for the hydroxylation of the C5 carbon of the ring. In this work, we have generated a human cell line lacking functional COQ6 using CRISPR/Cas9 technology. We show that these cells cannot synthesize CoQ and display severe ATP deficiency. Treatment with VA can recover CoQ biosynthesis and ATP production. Moreover, these cells display increased ROS production, which is only partially corrected by exogenous CoQ, while VA restores ROS to normal levels. Furthermore, we show that these cells accumulate 3-decaprenyl-1,4-benzoquinone, suggesting that in mammals, the decarboxylation and C1 hydroxylation reactions occur before or independently of the C5 hydroxylation. Finally, we show that COQ6 isoform c (transcript NM_182480) does not encode an active enzyme. VA can be produced in the liver by the oxidation of vanillin, a nontoxic compound commonly used as a food additive, and crosses the blood-brain barrier. These characteristics make it a promising compound for the treatment of patients with CoQ deficiency due to COQ6 mutations.


Subject(s)
Adenosine Triphosphate/metabolism , Ubiquinone/analogs & derivatives , Vanillic Acid/pharmacology , Amino Acid Sequence , Animals , CRISPR-Cas Systems/genetics , HEK293 Cells , Humans , Mitochondria/metabolism , Mutagenesis, Site-Directed , Protein Isoforms/genetics , Protein Isoforms/metabolism , Protein Structure, Tertiary , Reactive Oxygen Species/metabolism , Sequence Alignment , Ubiquinone/biosynthesis , Ubiquinone/genetics , Ubiquinone/metabolism
16.
J Biochem Mol Toxicol ; 33(10): e22382, 2019 Oct.
Article in English | MEDLINE | ID: mdl-31468657

ABSTRACT

Vanillic acid (VA) is found in high concentrations in various plants and used as traditional medicine for various diseases. The aim of the existing study is to illustrate the protective effects of VA against benzo(a)pyrene (B(a)P)-induced lung cancer in Swiss albino mice. B(a)P (50 mg/kg b.wt.) was given orally to induce lung cancer in mice. The body weight, tumor incidence, carcinoembryonic antigen (CEA), neuron-specific enolase (NSE), and enzymatic/nonenzymatic antioxidants (superoxide dismutase, catalase, glutathione reductase, glutathione peroxidase, and glutathione) were estimated. Further histochemical investigation through hematoxylin and eosin staining was also carried out. B(a)P administered groups showed increased levels of serum pathological markers CEA, NSE along with reduced final body weight as well as decreased tissue enzymatic and nonenzymatic antioxidants activities, whereas VA treatment (200mg/kg/b.wt) along with B(a)P showed significantly reverted the above changes, which proves as prominent anticancer effects in experimentally induced lung cancer. Overall, these results suggest that VA has an efficient preventive action against B(a)P-induced lung cancer, and this is attributed to its free-radical scavenging antioxidant activities.


Subject(s)
Benzo(a)pyrene/toxicity , Carcinogens/toxicity , Lung Neoplasms/chemically induced , Lung Neoplasms/prevention & control , Vanillic Acid/pharmacology , Animals , Antioxidants/metabolism , Carcinoembryonic Antigen/metabolism , Lung/drug effects , Lung/pathology , Lung Neoplasms/enzymology , Lung Neoplasms/metabolism , Male , Mice , Organ Size/drug effects , Phosphopyruvate Hydratase/metabolism
17.
Biosci Biotechnol Biochem ; 83(7): 1205-1215, 2019 Jul.
Article in English | MEDLINE | ID: mdl-30999826

ABSTRACT

Panax ginseng C. A. Meyer has been widely used in skin care. Our previous study showed that the phenolic acids in ginseng root extract (GRE) impart inhibitory effects on melanogenesis. In this study, we found that as the most abundant component of phenolic acids in GRE, vanillic acid decreased tyrosinase activity and melanin levels with or without α-MSH stimulation and suppressed the expression of microphthalmia-associated transcription factor (MITF) and melanogenic enzymes in B16F10 cells. Furthermore, vanillic acid downregulated NOS activity, nitric oxide (NO) content, cGMP level, guanylate cyclase (GC) and protein kinase G (PKG) activity, and the phosphorylation of cAMP-response element-binding protein (CREB), whereas arbutin had no effect on the NO/PKG pathway. These findings indicate that vanillic acid in GRE suppressed melanogenesis by inhibiting the NO/PKG signaling pathways. This study provides a potential mechanism underlying the inhibitory effect of ginseng on melanogenesis.


Subject(s)
Cyclic GMP-Dependent Protein Kinases/antagonists & inhibitors , Melanins/antagonists & inhibitors , Nitric Oxide/antagonists & inhibitors , Panax/chemistry , Plant Extracts/pharmacology , Plant Roots/chemistry , Signal Transduction/drug effects , Vanillic Acid/pharmacology , Animals , Cell Line, Tumor , Cyclic GMP-Dependent Protein Kinases/metabolism , Intramolecular Oxidoreductases/metabolism , Melanins/biosynthesis , Melanins/metabolism , Membrane Glycoproteins/metabolism , Mice , Microphthalmia-Associated Transcription Factor/metabolism , Monophenol Monooxygenase/metabolism , Nitric Oxide/metabolism , Nitric Oxide Synthase/metabolism , Oxidoreductases/metabolism , Up-Regulation/drug effects , alpha-MSH/pharmacology
18.
Pharmacol Rep ; 71(1): 67-72, 2019 Feb.
Article in English | MEDLINE | ID: mdl-30471518

ABSTRACT

BACKGROUND: Transient receptor potential ankyrin-1 (TRPA1) channels expressed in the central terminal of dorsal root ganglion neurons in the spinal substantia gelatinosa (SG) play a role in modulating nociceptive transmission. Although plant-derived compounds exhibiting antinociception (such as eugenol, carvacrol and thymol) activate TRPA1 channels to enhance spontaneous excitatory transmission while hyperpolarizing membranes in SG neurons without TRPA1 activation, specific chemical moieties involved in synaptic modulation are unknown. METHODS: We examined the effects of other plant-derived compounds (guaiacol, vanillin, vanillic acid and p-cymene) on holding current and spontaneous excitatory transmission at -70 mV by applying the whole-cell patch-clamp technique to SG neurons in adult rat spinal cord slices. RESULTS: None of the compounds affected the frequency or amplitude of spontaneous excitatory postsynaptic current. Guaiacol and vanillic acid had no effect on holding currents, while vanillin and p-cymene produced an inward and outward current, respectively, in some neurons tested. Synaptic modulation was also observed within the same neuron as the activities of eugenol, carvacrol, thymol, and the chemically-related plant-derived compound zingerone occurred. CONCLUSION: A substituted group in eugenol and zingerone, but not in guaiacol, vanillin or vanillic acid, as well as an OH bound to the benzene ring of carvacrol and thymol, but not p-cymene, play a role in producing outward current and TRPA1 activation. Thus, the binding of such chemical moeties to the benzene ring of plant-derived compounds appears necessary to modulate nociceptive transmission in the SG. This information provides insight for the development of new analgesics based on plant-derived compounds.


Subject(s)
Analgesics/pharmacology , Plant Extracts/pharmacology , Substantia Gelatinosa/drug effects , TRPA1 Cation Channel/agonists , Analgesics/chemistry , Animals , Benzaldehydes/chemistry , Benzaldehydes/pharmacology , Cymenes , Excitatory Postsynaptic Potentials/drug effects , Guaiacol/chemistry , Guaiacol/pharmacology , In Vitro Techniques , Male , Molecular Structure , Monoterpenes/chemistry , Monoterpenes/pharmacology , Plant Extracts/chemistry , Rats, Sprague-Dawley , Structure-Activity Relationship , Substantia Gelatinosa/metabolism , TRPA1 Cation Channel/metabolism , Vanillic Acid/chemistry , Vanillic Acid/pharmacology
19.
Pak J Pharm Sci ; 31(5): 1951-1957, 2018 Sep.
Article in English | MEDLINE | ID: mdl-30150194

ABSTRACT

In order to investigate the anti-inflammatory activity of flavonoids, phenolic acids, and alkaloids from the flowers of Trollius chinensis, some representative compounds, namely, orientin, 2"-O-ß-L-galactopyranosylorientin, vitexin, quercetin, isoquercetin, luteolin, veratric acid, proglobeflowery acid, trollioside, and trolline were selected to study their inhibitory effects against LPS-induced NO, IL-6, and TNF-ß release in RAW264.7 cells. At the higher concentration, both phenolic acids and flavonoids inhibited the production of NO, whereas only phenolic acids showed this effect at the lower concentration. Although trolline had stronger cytotoxicity, it exhibited a potential effect of decreasing NO production induced by LPS in the non-toxic concentration range. In addition, all tested compounds decreased the production of IL-6 and TNF-a by almost 50% at both the higher and lower concentrations. It is concluded that the anti-inflammatory activity of the phenolic acids is stronger than that of the flavonoids.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Cell Survival/drug effects , Flowers , Plant Extracts/pharmacology , Ranunculaceae , Vanillic Acid/analogs & derivatives , Alkaloids/isolation & purification , Alkaloids/pharmacology , Animals , Anti-Inflammatory Agents/isolation & purification , Apigenin/isolation & purification , Apigenin/pharmacology , Cell Survival/physiology , Dose-Response Relationship, Drug , Flavonoids/isolation & purification , Flavonoids/pharmacology , Glucosides/isolation & purification , Glucosides/pharmacology , Mice , Plant Extracts/isolation & purification , RAW 264.7 Cells , Vanillic Acid/isolation & purification , Vanillic Acid/pharmacology
20.
Molecules ; 23(3)2018 Mar 16.
Article in English | MEDLINE | ID: mdl-29547584

ABSTRACT

Black sesame pigment (BSP) represents a low cost, easily accessible material of plant origin exhibiting marked antioxidant and heavy metal-binding properties with potential as a food supplement. We report herein the inhibitory properties of the potentially bioaccessible fraction of BSP following simulated gastrointestinal digestion against key enzymes involved in Alzheimer's disease (AD). HPLC analysis indicated that BSP is transformed under the pH conditions mimicking the intestinal environment and the most abundant of the released compounds was identified as vanillic acid. More than 80% inhibition of acetylcholinesterase-induced aggregation of the ß-amyloid Aß1-40 was observed in the presence of the potentially bioaccessible fraction of BSP, which also efficiently inhibited self-induced Aß1-42 aggregation and ß-secretase (BACE-1) activity, even at high dilution. These properties open new perspectives toward the use of BSP as an ingredient of functional food or as a food supplement for the prevention of AD.


Subject(s)
Alzheimer Disease/prevention & control , Amyloid beta-Peptides/chemistry , Cholinesterase Inhibitors/isolation & purification , Peptide Fragments/chemistry , Sesamum/chemistry , Vanillic Acid/isolation & purification , Alzheimer Disease/enzymology , Alzheimer Disease/metabolism , Cholinesterase Inhibitors/chemistry , Cholinesterase Inhibitors/pharmacology , Chromatography, High Pressure Liquid , Humans , Molecular Structure , Pigments, Biological/analysis , Pigments, Biological/chemistry , Pigments, Biological/pharmacology , Plant Extracts/analysis , Plant Extracts/chemistry , Plant Extracts/pharmacology , Protein Aggregates/drug effects , Vanillic Acid/chemistry , Vanillic Acid/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL